Page:Washington v. U.S. Food and Drug Administration (E.D. Wash. 2023).pdf/30

 Bros. Dairy, 54 F. Supp. 2d 974, 975 (E.D. Wash. 1999) (internal citations omitted).

While these motions are unopposed, the proposed briefs offer no additional legal or substantive information that is particularly helpful to the Court’s findings on the present motion. The briefs may be more useful during a trial on the merits. Therefore, the motions are denied.

ACCORDINGLY, IT IS HEREBY ORDERED:
 * 1) Plaintiffs’ Motion for Preliminary Injunction (ECF No. 3) is GRANTED in part.
 * 2) Pursuant to Federal Rule of Civil Procedure 65(a), Defendants and their officers, agents, servants, employees, attorneys, and any person in active concert or participation, are PRELIMINARILY ENJOINED from:
 * “altering the status quo and rights as it relates to the availability of Mifepristone under the current operative January 2023 Risk Evaluation and Mitigation Strategy under 21 U.S.C. § 355-1 in Plaintiff States.”
 * 1) No bond shall be required. Fed. R. Civ. P. 65(c).
 * 2) Third Parties’ Unopposed Motion for Leave to File Amicus Curiae Brief (ECF No. 52) is DENIED.